Didric Cederholm Portfolio
Invests via Lion Point Capital LP | Managed by Didric Cederholm, Jim Freeman
Invests via Lion Point Capital LP
Managed by Didric Cederholm, Jim Freeman
Automatically Tracked
Active in Nordic venture circles, Didric Cederholm is an angel investor and operator who blends hands-on product and growth experience with early-stage capital deployment. He invests primarily into SaaS, fintech and developer tooling companies across Northern Europe, writing direct checks and leading small syndicates while providing go-to-market support. His background includes founding and scaling startups, early-team product leadership, and board-advisory roles that help translate technical roadmaps into commercial traction. Capital partners and founders cite his operational involvement as a catalyst for Series A readiness, and he sources deals through operator networks and founder referrals. Investment scope centers on pre-seed to Series A rounds with an emphasis on founder-led technical teams and measurable ARR or user-growth signals.
Active in Nordic venture circles, Didric Cederholm is an angel investor and operator who blends hands-on product and growth experience with early-stage capital deployment. He invests primarily into SaaS, fintech and developer tooling companies across Northern Europe, writing direct checks and leading small syndicates while providing go-to-market support. His background includes founding and scaling startups, early-team product leadership, and board-advisory roles that help translate technical roadmaps into commercial traction. Capital partners and founders cite his operational involvement as a catalyst for Series A readiness, and he sources deals through operator networks and founder referrals. Investment scope centers on pre-seed to Series A rounds with an emphasis on founder-led technical teams and measurable ARR or user-growth signals.
Investment Philosophy & Strategy
Operator-led angel strategy focused on pre-seed to Series A SaaS, fintech and developer tooling in Northern Europe. Prioritises founder-led technical teams with measurable ARR or user-growth signals, deploying concentrated checks and leading small syndicates. Emphasises capital efficiency and milestone-driven follow-ons, pairing go-to-market and product growth support to accelerate Series A readiness. Underwrites opportunities through operator networks and referrals, prefers pragmatic risk management via hands-on board/advisory involvement and clear commercial traction metrics.
Operator-led angel strategy focused on pre-seed to Series A SaaS, fintech and developer tooling in Northern Europe. Prioritises founder-led technical teams with measurable ARR or user-growth signals, deploying concentrated checks and leading small syndicates. Emphasises capital efficiency and milestone-driven follow-ons, pairing go-to-market and product growth support to accelerate Series A readiness. Underwrites opportunities through operator networks and referrals, prefers pragmatic risk management via hands-on board/advisory involvement and clear commercial traction metrics.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
9.76%
Gain
Monthly
0.79%
Yearly
9.84%
Drawdown
41.89%
$21.14M
Equity
Holdings
$21.14M
Investment
$18.65M
$326.45M
Profit -$430,918.03
Realized
$323.96M
Unrealized
$2.49M
Dividends
$21M
Goals
Avg. 100% completed goals
Yearly
Gain > 9% 2026
Yearly
Loss < 33% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0%
Profit
-$430,918.03
Win %
61%
This Week
Compared To Last Week
Gain
-1.28%
Profit
-$273,906.54
Win %
61%
This Month
Compared to last month
Gain
1.09%
Profit
$227,083.79
Win %
61%
This Year
Compared to last year
Gain
26.66%
Profit
$4.46M
Win %
63%
AZTA Azenta, Inc.
+4.02%
+$9,922.13 
ARQT Arcutis Biotherapeutics Inc.
+3.5%
+$4,930.27 
LNTH Lantheus Holdings, Inc.
+2.54%
+$14,285.15 
GERN Geron Corporation
+1.51%
+$12,080.2 
PCRX Pacira BioSciences Inc.
+1.04%
+$3,510 
JANX Janux Therapeutics Inc.
+1.01%
+$3,040 
MCRB Seres Therapeutics, Inc.
+0.94%
+$1,578.5 
INVA Innoviva Inc.
+0.87%
+$1,558 
ARDX Ardelyx Inc.
+0.87%
+$5,789.25 
VTRS Viatris Inc.
+0.67%
+$3,047 
RPRX Royalty Pharma plc
+0.67%
+$7,977.92 
IRON Disc Medicine Inc.
+0.4%
+$2,417.04 
RCKT Rocket Pharmaceuticals Inc.
+0.17%
+$541.8 
JSPR Jasper Therapeutics Inc.
-7.94%
-$26,691 
CUE Cue Biopharma, Inc.
-7.58%
-$172,285.21 
CMPS Compass Pathways plc Depositary Receipt
-5.15%
-$55,200 
SRPT Sarepta Therapeutics Inc.
-4.79%
-$24,510 
FENC Fennec Pharmaceuticals Inc.
-4.17%
-$52,281.81 
IPHA Innate Pharma S.A. Sponsored ADR
-3.85%
-$5,680.57 
MIST Milestone Pharmaceuticals Inc.
-3.46%
-$36,900 
PRAX Praxis Precision Medicines Inc.
-2.92%
-$42,643.46 
RGNX Regenxbio Inc.
-2.85%
-$9,310 
QURE uniQure N.V.
-2.82%
-$17,207.82 
SPRB Spruce Biosciences Inc.
-2.33%
-$1,080 
BBIO BridgeBio Pharma, Inc.
-2.1%
-$8,850 
MLYS Mineralys Therapeutics, Inc.
-2.03%
-$5,821.2 
BHVN Biohaven Ltd.
-1.47%
-$11,374 
SNDX Syndax Pharmaceuticals Inc.
-1.43%
-$12,380.4 
BNTC Benitec Biopharma Inc.
-1.16%
-$9,300 
DYN Dyne Therapeutics Inc.
-1.09%
-$4,680 
HUMA Humacyte, Inc.
-0.83%
-$3,835 
GHRS GH Research plc
-0.39%
-$1,071 
KURA Kura Oncology Inc.
-0.36%
-$1,840 
EWTX Edgewise Therapeutics, Inc.
-0.2%
-$728 
MLTX MoonLake Immunotherapeutics
-0.01%
-$202.5 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 496 | Longs Won 265/496 53% | Profit Factor 1.89 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $5.93M |
| Average Win $2.61M | Best Trade (Dec 31) $64.29M | Sharpe Ratio -59.84 |
| Average Loss -$1.58M | Worst Trade (Sep 29) -$37.03M | Z-Score -1.93 (97.17%) |
| Commissions $0 | Avg. Trade Length 1y 3m 4d | Expectancy $658,158.76 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 21.21% | 33.83% | 44.45% | 53.95% | 62.7% | 70.89% | 78.65% | 86.05% | 93.15% |
| Consecutive Losing Trades | 13 | 12 | 11 | 9 | 8 | 7 | 5 | 4 | 3 | 1 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
